RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 26.00
+1.50 (6.12%)
Jul 28, 2026, 8:33 AM GMT
RUA Life Sciences Income Statement
Financials in millions GBP. Fiscal year is October - September.
Millions GBP. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 4.62 | 4.46 | 4.11 | 2.19 | 2.18 | 1.63 |
| 4.62 | 4.46 | 4.11 | 2.19 | 2.18 | 1.63 | |
Revenue Growth | 3.54% | 8.42% | 87.72% | 0.55% | 34.09% | 6.35% |
Cost of Revenue | 1.01 | 1 | 0.94 | 0.48 | 0.45 | 0.35 |
Gross Profit | 3.61 | 3.46 | 3.17 | 1.72 | 1.73 | 1.27 |
Selling, General & Admin | 3.38 | 3.53 | 4.16 | 2.48 | 2.61 | 2.17 |
Research & Development | 0.29 | 0.29 | - | 0.87 | 1.07 | 0.91 |
Other Operating Expenses | -0.64 | -0.64 | -0.97 | -0.06 | -0.01 | 0.22 |
Operating Expenses | 3.48 | 3.63 | 3.19 | 3.65 | 4.03 | 3.62 |
Operating Income | 0.14 | -0.17 | -0.02 | -1.94 | -2.31 | -2.35 |
Interest Expense | - | - | - | -0.08 | -0.02 | -0.01 |
Interest & Investment Income | 0.02 | 0.01 | 0.01 | - | - | - |
EBT Excluding Unusual Items | 0.16 | -0.16 | -0.01 | -2.02 | -2.32 | -2.36 |
Other Unusual Items | 0.14 | - | - | - | - | - |
Pretax Income | 0.3 | -0.16 | -0.01 | -2.02 | -2.32 | -2.36 |
Income Tax Expense | 0.02 | -0 | -0.01 | -0.58 | -0.32 | -0.29 |
Earnings From Continuing Operations | 0.28 | -0.16 | 0 | -1.44 | -2 | -2.07 |
Minority Interest in Earnings | 0.01 | 0.01 | - | - | - | - |
Net Income | 0.28 | -0.15 | 0 | -1.44 | -2 | -2.07 |
Net Income to Common | 0.28 | -0.15 | 0 | -1.44 | -2 | -2.07 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 62 | 62 | 62 | 34 | 22 | 22 |
Shares Outstanding (Diluted) | 62 | 62 | 62 | 34 | 22 | 22 |
Shares Change | - | - | 85.00% | 51.21% | - | 25.36% |
EPS (Basic) | 0.00 | -0.00 | 0.00 | -0.04 | -0.09 | -0.09 |
EPS (Diluted) | 0.00 | -0.00 | 0.00 | -0.04 | -0.09 | -0.09 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -1.02 | -0.24 | -0.28 | -1.38 | -1.6 | -3.26 |
Free Cash Flow Per Share | -0.02 | -0.00 | -0.01 | -0.04 | -0.07 | -0.15 |
Gross Margin | 78.20% | 77.50% | 77.12% | 78.32% | 79.30% | 78.22% |
Operating Margin | 2.94% | -3.84% | -0.49% | -88.41% | -105.83% | -144.74% |
Profit Margin | 6.10% | -3.26% | 0.02% | -65.72% | -91.92% | -127.20% |
Free Cash Flow Margin | -22.11% | -5.29% | -6.83% | -63.12% | -73.20% | -200.43% |
EBITDA | 0.58 | 0.27 | 0.4 | -1.57 | -1.95 | -2.04 |
EBITDA Margin | 12.45% | 6.10% | 9.75% | -71.79% | -89.40% | -125.72% |
D&A For EBITDA | 0.44 | 0.44 | 0.42 | 0.36 | 0.36 | 0.31 |
EBIT | 0.14 | -0.17 | -0.02 | -1.94 | -2.31 | -2.35 |
EBIT Margin | 2.94% | -3.84% | -0.49% | -88.41% | -105.83% | -144.74% |
Advertising Expenses | - | - | - | 0.01 | 0.02 | 0.01 |